Book a Demo

Conduct assessments with speed, precision, and confidence

Reduce evaluation time from weeks to hours without sacrificing depth. Verix enables faster decisions by replacing manual, one-off analyses with automated forecasting powered by real-world data.

Gain unmatched clarity with patient-level analytics, epidemiology modeling, and prescribing behavior insights—helping you accurately quantify market size, risk, and potential ROI.

Built for scale, the platform adapts to any therapy area or product type, making it easy to evaluate more opportunities, more often, without increasing your workload or budget.

anim
anim
Read Case Study

Intelligently navigate complex markets

Uncover high-value opportunities—faster

Harness real-world data, automation, and advanced analytics to cut evaluation time by >10X and costs by >50%.

anim
anim

Robust Out-of-the Box Analytics Capabilites

icon

Market Size & Map

Rapidly analyze claims data (Mx & Rx) to define market potential, identify therapeutic overlaps & assess competitive positioning.

icon

Patient-Based Forecast

Model market value using real-world diagnosis, treatment, and adherence data.

icon

Monte Carlo Simulator

Evaluate uncertainty and risk in your forecasts with automated scenario modeling.

icon

Natural Patient History

Understand the full patient journey—onset, diagnosis, treatment patterns, and progression.

icon

Sales Force Sizing

Estimate optimal field force size based on market coverage needs and overlaps.

icon

Epidemiology Insights

Extract relevant data from studies and databases to refine population assumptions.

anim

In Their Own Words

VP US Commercial Strategy, Partnerships, and BD&L

"What we used to do in months of analysis for a single therapeutic we can now do with Tovana in a couple of days – analyzing every aspect of an opportunity, including market potential, competition, required sales force, and more."


"We have to kiss a lot of frogs before finding the right investment. There's always time pressure as there's competition for good opportunities. We need to identify them quickly and make a move."

anim

FAQ

  • What is Opportunity Assessment in pharma business development?
    It evaluates the commercial potential of pharma assets using real-world data, automation, and advanced analytics.
  • What insights does Opportunity Assessment provide for asset evaluation?
    It provides a patient-based view of market size, epidemiology, treatment rates, competitive landscape, and revenue potential. This allows teams to evaluate commercial upside and downside before making investment decisions.
  • How does Opportunity Assessment reduce investment risk and uncertainty?
    It models a range of realistic market scenarios using real-world patient data, helping teams understand upside, downside, and confidence ranges before making investment decisions.
  • How fast can we evaluate multiple assets, indications, or markets?
    Fast turnaround times enable assessments in days instead of weeks, while a single license supports unlimited evaluations across assets, indications, and markets.
  • What strategic value does Opportunity Assessment deliver for BD teams?
    It enables faster, more consistent, and more scalable evaluations, reducing reliance on one-off analyses while improving decision confidence across the portfolio.

See Verix
in action!

Want to see how you can
improve HCP engagement
and grow revenue?